A collaboration between artificial intelligence (AI) biotech Insilico Medicine and the University of Cambridge has presented a new technique to identify drug targets for diseases where protein phase separation regulation is abnormal, such as Alzheimer’s and Parkinson’s disease and some cancers.Using a combination of Insilico’s AI-driven target identification engine PandaOmics and the FuzDrop method for […]
